(XMTR) Xometry - Overview
Stock: Marketplace, Quoting, Sourcing, Software, Manufacturing
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 70.7% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.07 |
| Alpha | 57.26 |
| Character TTM | |
|---|---|
| Beta | 1.612 |
| Beta Downside | 1.859 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.44% |
| CAGR/Max DD | 0.35 |
Description: XMTR Xometry January 14, 2026
Xometry, Inc. (NASDAQ: XMTR) runs an AI-driven online marketplace that matches buyers of custom-manufactured parts with a global network of suppliers. Its core products include the Xometry marketplace for instant quoting, the Thomasnet industrial directory, and cloud-based workflow tools such as Workcenter (payments) and Teamspace (collaboration). The platform spans a full suite of manufacturing capabilities-from CNC machining and sheet-metal forming to 3D printing and injection molding-serving sectors like aerospace, automotive, medical devices, and defense.
From a financial standpoint, Xometry reported FY 2023 revenue of roughly $1.07 billion, a 61 % year-over-year increase, and a gross margin near 38 %, reflecting the scalability of its AI quoting engine. The company’s cash balance exceeded $300 million at year-end, providing runway for continued supplier acquisition and technology investment. A key macro driver is the ongoing shortage of domestic manufacturing capacity, which is pushing OEMs toward on-demand, digitally-enabled sourcing solutions-a trend that underpins Xometry’s growth outlook.
Strategically, Xometry’s expansion into value-added services (e.g., financial settlement via Workcenter) and its integration of the Thomasnet directory enhance network effects, creating higher switching costs for both buyers and suppliers. However, the business remains exposed to competitive pressure from both traditional distributors and emerging digital platforms, and its valuation is sensitive to assumptions about sustained high-growth rates in the broader on-demand manufacturing market.
For a deeper dive into Xometry’s valuation metrics and competitive positioning, the ValueRay platform offers a concise, data-rich snapshot worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -63.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 4.78 > 1.0 |
| NWC/Revenue: 38.42% < 20% (prev 48.52%; Δ -10.10% < -1%) |
| CFO/TA 0.02 > 3% & CFO 10.7m > Net Income -63.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.9m) vs 12m ago 3.32% < -2% |
| Gross Margin: 39.29% > 18% (prev 0.39%; Δ 3890 % > 0.5%) |
| Asset Turnover: 93.35% > 50% (prev 77.43%; Δ 15.92% > 0%) |
| Interest Coverage Ratio: -12.04 > 6 (EBITDA TTM -40.1m / Interest Expense TTM 4.84m) |
Altman Z'' -1.26
| A: 0.35 (Total Current Assets 341.1m - Total Current Liabilities 94.1m) / Total Assets 698.9m |
| B: -0.61 (Retained Earnings -423.4m / Total Assets 698.9m) |
| C: -0.08 (EBIT TTM -58.2m / Avg Total Assets 688.5m) |
| D: -0.98 (Book Value of Equity -418.9m / Total Liabilities 425.8m) |
| Altman-Z'' Score: -1.26 = CCC |
Beneish M -2.98
| DSRI: 1.03 (Receivables 98.9m/78.5m, Revenue 642.8m/525.1m) |
| GMI: 1.00 (GM 39.29% / 39.17%) |
| AQI: 0.96 (AQ_t 0.43 / AQ_t-1 0.44) |
| SGI: 1.22 (Revenue 642.8m / 525.1m) |
| TATA: -0.11 (NI -63.0m - CFO 10.7m) / TA 698.9m) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of XMTR shares?
Over the past week, the price has changed by +15.58%, over one month by -2.73%, over three months by +6.47% and over the past year by +82.35%.
Is XMTR a buy, sell or hold?
- StrongBuy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the XMTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65.4 | -0.9% |
| Analysts Target Price | 65.4 | -0.9% |
| ValueRay Target Price | 73.2 | 10.8% |
XMTR Fundamental Data Overview February 05, 2026
P/S = 4.9312
P/B = 11.6528
Revenue TTM = 642.8m USD
EBIT TTM = -58.2m USD
EBITDA TTM = -40.1m USD
Long Term Debt = 326.9m USD (from longTermDebt, last quarter)
Short Term Debt = 2.55m USD (from shortTermDebt, last quarter)
Debt = 333.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 312.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.28b USD (3.17b + Debt 333.5m - CCE 224.5m)
Interest Coverage Ratio = -12.04 (Ebit TTM -58.2m / Interest Expense TTM 4.84m)
EV/FCF = -239.2x (Enterprise Value 3.28b / FCF TTM -13.7m)
FCF Yield = -0.42% (FCF TTM -13.7m / Enterprise Value 3.28b)
FCF Margin = -2.13% (FCF TTM -13.7m / Revenue TTM 642.8m)
Net Margin = -9.80% (Net Income TTM -63.0m / Revenue TTM 642.8m)
Gross Margin = 39.29% ((Revenue TTM 642.8m - Cost of Revenue TTM 390.2m) / Revenue TTM)
Gross Margin QoQ = 39.86% (prev 40.10%)
Tobins Q-Ratio = 4.69 (Enterprise Value 3.28b / Total Assets 698.9m)
Interest Expense / Debt = 0.38% (Interest Expense 1.28m / Debt 333.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -46.0m (EBIT -58.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.62 (Total Current Assets 341.1m / Total Current Liabilities 94.1m)
Debt / Equity = 1.23 (Debt 333.5m / totalStockholderEquity, last quarter 272.0m)
Debt / EBITDA = -7.80 (negative EBITDA) (Net Debt 312.6m / EBITDA -40.1m)
Debt / FCF = -22.81 (negative FCF - burning cash) (Net Debt 312.6m / FCF TTM -13.7m)
Total Stockholder Equity = 291.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -9.15% (Net Income -63.0m / Total Assets 698.9m)
RoE = -21.60% (Net Income TTM -63.0m / Total Stockholder Equity 291.7m)
RoCE = -9.41% (EBIT -58.2m / Capital Employed (Equity 291.7m + L.T.Debt 326.9m))
RoIC = -7.71% (negative operating profit) (NOPAT -46.0m / Invested Capital 596.9m)
WACC = 10.75% (E(3.17b)/V(3.50b) * Re(11.85%) + D(333.5m)/V(3.50b) * Rd(0.38%) * (1-Tc(0.21)))
Discount Rate = 11.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.89%
Fair Price DCF = unknown (Cash Flow -13.7m)
EPS Correlation: 26.89 | EPS CAGR: 20.82% | SUE: -0.53 | # QB: 0
Revenue Correlation: 96.57 | Revenue CAGR: 30.24% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=+0.006 | Revisions Net=+1 | Analysts=8
EPS next Year (2026-12-31): EPS=0.76 | Chg30d=-0.012 | Revisions Net=-2 | Growth EPS=+127.8% | Growth Revenue=+20.2%